keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Vapreotide acetate (BMY-41606 acetate) is an antagonist of the neurokinin-1 (NK1) receptor (IC50: 330 nM).
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 8,000 | |||
2 mg | 在庫あり | ¥ 11,000 | |||
5 mg | 在庫あり | ¥ 18,500 | |||
10 mg | 在庫あり | ¥ 28,000 | |||
25 mg | 在庫あり | ¥ 45,500 | |||
50 mg | 在庫あり | ¥ 85,000 | |||
100 mg | 在庫あり | ¥ 122,000 |
説明 | Vapreotide acetate (BMY-41606 acetate) is an antagonist of the neurokinin-1 (NK1) receptor (IC50: 330 nM). |
ターゲット&IC50 | NK1:330 nM |
In vitro | In a dose-dependent manner, Vapreotide attenuates the Substance P (SP)-triggered intracellular calcium increases and NF-κB activation.in HEK293-NK1R and U373MG cell lines, Vapreotide inhibits SP-induced IL-8 and MCP-1 production. In vitro, Vapreotide inhibits HIV-1 infection of human MDM, an effect that is reversible by SP pretreatment [1]. Vapreotide significantly inhibits GH-, PRL, and/or alpha-subunit release by human GH-secreting pituitary adenoma cells in concentrations as low as 10(-12)-10(-14) M. Vapreotide inhibits GH release (IC50: 0.1 pM) [2]. Vapreotide exhibits moderate-to-high affinities for SSTR2, -3, and -5 with IC50 of 0.17, 0.1, and 21 nM, respectively, and low affinity for SSTR1 and -4 with IC50 of 200 and 620 nM, respectively. RC-160 inhibits serum-induced proliferation of CHO cells expressing SSTR2 and SSTR5 (EC50s: 53 and 150 pM) [3]. |
In vivo | Acute vapreotide administration in rats reduces blood flow in collateral circulation, a critical factor in oesophagogastric variceal bleeding due to portal hypertension in cirrhosis, while its prolonged use slows down the development of such complications. Concurrently, RC-160 significantly diminishes tumor size and weight by approximately 40% through subcutaneous injections at a dosage of 100 μg/day/animal. Early-stage intervention with vapreotide is effective in curbing the progression of androgen-independent prostate cancer. |
別名 | RC-160 acetate, BMY-41606 acetate |
分子量 | 1191.42 |
分子式 | C59H74N12O11S2 |
CAS No. | 849479-74-9 |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 14 mg/mL (11.75 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Vapreotide acetate 849479-74-9 GPCR/G Protein Neuroscience Neurokinin receptor Vapreotide BMY-41606 BMY41606 RC-160 acetate BMY41606 Acetate RC-160 Acetate NK receptor Tachykinin receptor BMY 41606 Acetate RC160 Acetate RC 160 BMY 41606 Vapreotide Acetate RC 160 Acetate BMY-41606 Acetate RC160 Inhibitor RC-160 inhibit BMY-41606 acetate Neurokinin Receptor inhibitor